Literature DB >> 9934577

Diversion colitis--new light through old windows.

C M Edwards1, B George, B Warren.   

Abstract

Diversion proctocolitis is an iatrogenic disorder caused by surgical diversion of the faecal stream away from the colorectal mucosa. Such surgery may be necessary in cases of tumour, trauma or inflammatory conditions of the colorectum. Histopathological change is characterized by a chronic lymphoplasmacytic inflammatory infiltrate, and the hallmark feature, lymphoid follicular hyperplasia. Histological appearances are determined by the disease state of the colonic mucosa prior to faecal diversion. Macroscopic appearances may vary considerably, but often include aphthoid ulceration. The exact pathogenesis of the condition remains unclear, but the removal of short-chain fatty acids, present in the faecal stream, is considered an important aetiological factor. Current research areas, including the microbiology and cellular kinetics of diversion colitis, are discussed along with clinical features and treatments.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934577     DOI: 10.1046/j.1365-2559.1999.00624.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  11 in total

Review 1.  Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded.

Authors:  Tze S Khor; Hiroshi Fujita; Koji Nagata; Michio Shimizu; Gregory Y Lauwers
Journal:  J Gastroenterol       Date:  2012-02-10       Impact factor: 7.527

2.  Recurrent severe gastrointestinal bleeding and malabsorption due to extensive habitual megacolon.

Authors:  Ingo Mecklenburg; Markus Leibig; Christof Weber; Stefan Schmidbauer; Christian Folwaczny
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

3.  Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis.

Authors:  Amy J Thorsen
Journal:  Clin Colon Rectal Surg       Date:  2007-02

4.  Refractory diversion neovaginitis in a sigmoid-colon-derived neovagina: clinical and histopathological considerations.

Authors:  W B van der Sluis; M Bouman; Wjhj Meijerink; E A Neefjes-Borst; A A van Bodegraven
Journal:  Frontline Gastroenterol       Date:  2015-06-04

5.  Enemas with N-acetylcysteine can reduce the level of oxidative damage in cells of the colonic mucosa diverted from the faecal stream.

Authors:  Carlos Augusto Real Martinez; Marcos Gonçalves de Almeida; Camila Moraes Gonçalves da Silva; Marcelo Lima Ribeiro; Fernando Lorenzetti da Cunha; Murilo Rocha Rodrigues; Daniela Tiemi Sato; José Aires Pereira
Journal:  Dig Dis Sci       Date:  2013-07-05       Impact factor: 3.199

6.  Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis.

Authors:  Rodrigo Goulart Pacheco; Christiano Costa Esposito; Lucas C M Müller; Morgana T L Castelo-Branco; Leonardo Pereira Quintella; Vera Lucia A Chagas; Heitor Siffert P de Souza; Alberto Schanaider
Journal:  World J Gastroenterol       Date:  2012-08-28       Impact factor: 5.742

7.  Spectrum of non-inflammatory bowel disease and non-infectious colitis.

Authors:  Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

8.  Transverse loop colostomy and colonic motility.

Authors:  F Pucciani; M N Ringressi; G Maltinti; P Bechi
Journal:  Tech Coloproctol       Date:  2014-06-28       Impact factor: 3.781

9.  Deviation of the Fecal Stream in Colonic Bowel Segments Results in Increased Numbers of Isolated Lymphoid Follicles in the Submucosal Compartment in a Novel Murine Model of Diversion Colitis.

Authors:  Annabel Kleinwort; Paula Döring; Christine Hackbarth; Claus-Dieter Heidecke; Tobias Schulze
Journal:  Biomed Res Int       Date:  2017-08-13       Impact factor: 3.411

Review 10.  Diversion colitis and pouchitis: A mini-review.

Authors:  Kentaro Tominaga; Kenya Kamimura; Kazuya Takahashi; Junji Yokoyama; Satoshi Yamagiwa; Shuji Terai
Journal:  World J Gastroenterol       Date:  2018-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.